Since it is crucial to target TERT in senescence induction of CML, indirect regulation via IM would result in the ineffective inactivation of upstream factors as TERT is a downstream effector of BCR-ABL, STAT5, and c-MYc. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.